Cargando…
Machine Learning–Based Analysis of Treatment Sequences Typology in Advanced Non–Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab
Immune checkpoint inhibitors substantially changed advanced non–small-cell lung cancer (aNSCLC) management and can lead to long-term survival. The aims of this study were (1) to use a machine learning method to establish a typology of treatment sequences on patients with aNSCLC who were alive 2 year...
Autores principales: | Chouaïd, Christos, Grumberg, Valentine, Batisse, Alexandre, Corre, Romain, Giaj Levra, Matteo, Gaudin, Anne-Françoise, Prodel, Martin, Lortet-Tieulent, Joannie, Assié, Jean-Baptiste, Cotté, Francois-Emery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824409/ https://www.ncbi.nlm.nih.gov/pubmed/35113656 http://dx.doi.org/10.1200/CCI.21.00108 |
Ejemplares similares
-
Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)
por: Assié, Jean-Baptiste, et al.
Publicado: (2020) -
Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting
por: Assié, Jean-Baptiste, et al.
Publicado: (2023) -
Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database
por: Tredan, Olivier, et al.
Publicado: (2022) -
Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France
por: Bregman, Bruno, et al.
Publicado: (2020) -
Thyroid cancer “epidemic” also occurs in low‐ and middle‐income countries
por: Lortet‐Tieulent, Joannie, et al.
Publicado: (2018)